Back
Jaguar Health, Inc. 10K Form
Sell
13
JAGX
Jaguar Health, Inc.
Last Price:
$1.09
Seasonality Move:
107.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive JAGX News And Ratings
See the #1 stock for the next 7 days that we like better than JAGX
JAGX Financial Statistics
Sales & Book Value
| Annual Sales: | $11.7M |
|---|---|
| Cash Flow: | $-4.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.85 |
| Price / Book: | 0.41 |
Profitability
| EPS (TTM): | -52.00560 |
|---|---|
| Net Income (TTM): | $-41M |
| Gross Margin: | $7.4M |
| Return on Equity: | -524.57% |
| Return on Assets: | -78.59% |
Jaguar Health, Inc. Earnings Forecast
Key Jaguar Health, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for JAGX is 63.10%.
-
The Selling, General & Administrative Expenses for JAGX have been equal to 205.52% of Gross Profit Margin.
-
The Research & Development expenses have been 141.52% of Revenue.
-
The Net Earning history of JAGX is -335.79% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 8 years.
Jaguar Health, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | JAGX |
| CUSIP: | 47010C |
| Website: | jaguar.health |
Debt
| Debt-to-Equity Ratio: | 5.67 |
|---|---|
| Current Ratio: | 0.81 |
| Quick Ratio: | 0.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
JAGX Technical Analysis vs Fundamental Analysis
Sell
13
Jaguar Health, Inc. (JAGX)
is a Sell
Is Jaguar Health, Inc. a Buy or a Sell?
-
Jaguar Health, Inc. stock is rated a SellThe current Jaguar Health, Inc. [JAGX] share price is $1.02. The Score for JAGX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.